首页> 外文OA文献 >Investigation of solvent effect and NMR shielding tensors of p53 tumor-suppressor gene in drug design
【2h】

Investigation of solvent effect and NMR shielding tensors of p53 tumor-suppressor gene in drug design

机译:p53肿瘤抑制基因在药物设计中的溶剂效应和NMR屏蔽张量的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The p53 tumor-suppressor gene encodes a nuclear phosphoprotein with cancer- inhibiting properties. The most probable cancerous mutations occur as point mutations in exons 5 up to 8 of p53, as a base pair substitution that encompasses CUA and GAT sequences. As DNA drug design represents a direct genetic treatment of cancer, in the research reported computational drug design was carried out to explore, at the Hartree–Fock level, effects of solvents on the thermochemical properties and nuclear magnetic resonance (NMR) shielding tensors of some atoms of CUA involved in the hydrogen-bonding network. The observed NMR shielding variations of the solutes caused by solvent change seemed significant and were attributed to solvent polarity, and solute–solvent and solvent–solute hydrogen-bonding interactions. The results provide a reliable insight into the nature of mutation processes. However, to improve our knowledge of the hydration pattern more rigorous computations of the hydrated complexes are needed.
机译:p53肿瘤抑制基因编码具有癌抑制特性的核磷蛋白。最可能的癌性突变是p53的第5至第8外显子中的点突变,其是包含CUA和GAT序列的碱基对取代。由于DNA药物设计代表了癌症的直接基因治疗,因此该研究报告称进行了计算药物设计,以探索在Hartree-Fock级别上溶剂对某些分子的热化学性质和核磁共振(NMR)屏蔽张量的影响。 CUA原子参与氢键网络。观察到的由溶剂变化引起的溶质的NMR屏蔽变化似乎很明显,并且归因于溶剂的极性以及溶质-溶剂和溶质-溶质氢键相互作用。结果为突变过程的性质提供了可靠的见解。但是,为了提高我们对水合模式的了解,需要对水合配合物进行更严格的计算。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号